mhurhangee/patent-ind-claim-en huggingface dataset:
An air conditioner , the air conditioner having a housing , a compressor and at least one fastening device for the compressor in the housing , the compressor having at least one mounting component , the mounting component and the fastening device being configured and connected to each other such that the compressor is fastened on a bottom of the housing , the fastening device having at least one clamping element , a guiding element and two stop elements , the guiding element being arranged in a recess of the bottom of the housing , a length of the guiding element being shorter than a height of the recess , the stop elements being each associated with a front side of the clamping element , an axial distance between the stop elements being variable in an unassembled state, and an axial distance between the stop elements being fixed in an assembled state. the air conditioner having a housing , a compressor and at least one fastening device for the compressor in the housing , the compressor having at least one mounting component , the mounting component and the fastening device being configured and connected to each other such that the compressor is fastened on a bottom of the housing , the fastening device having at least one clamping element , a guiding element and two stop elements , the guiding element being arranged in a recess of the bottom of the housing , a length of the guiding element being shorter than a height of the recess , the stop elements being each associated with a front side of the clamping element , an axial distance between the stop elements being variable in an unassembled state, and an axial distance between the stop elements being fixed in an assembled state.
Method (M) for the resistance welding of two fibre-composite components to give a fibre-composite structure , which comprises: arranging (M1) conductive fibres within a jointing region of the two fibre-composite components , where each conductive fibre comprises a carbon fibre being coated with an electrically insulating coating , passing (M2) an electric current through the conductive fibres in a manner that heats the jointing region to a welding temperature and melts the fibre-composite components in the jointing region ; and hardening (M5) the jointing region in a manner that bonds the two fibre-composite components by way of the jointing region to give the fibre-composite structure ; characterised in that the electrically insulating coating is a solid polymer-electrolyte coating. arranging (M1) conductive fibres within a jointing region of the two fibre-composite components , where each conductive fibre comprises a carbon fibre being coated with an electrically insulating coating , passing (M2) an electric current through the conductive fibres in a manner that heats the jointing region to a welding temperature and melts the fibre-composite components in the jointing region ; and hardening (M5) the jointing region in a manner that bonds the two fibre-composite components by way of the jointing region to give the fibre-composite structure ; characterised in that the electrically insulating coating is a solid polymer-electrolyte coating.
A compound for use in a method for decreasing a risk of suicidal behaviour in a bipolar I disorder patient, wherein the bipolar I disorder patient is undergoing treatment of bipolar I disorder, wherein the compound is endoxifen citrate, and wherein the method comprises: maintaining a therapeutically effective concentration of endoxifen in the patient by administrating a dose of 2 mg to 16 mg of endoxifen citrate in an enteric coated tablet once per day for at least 21 days.
A method, comprising: determining, by a processor of a device during a system startup phase that starts privileged software processes that initialize the device and that is prior to transitioning to a device operational phase wherein any software present on the device is able to execute, a respective starting fingerprint of memory of each executing process within at least one process other than a kernel process, each executing process in the at least one process being started after the kernel process and during the system startup phase; determining, by the processor during the device operational phase and while a selected executing process is executing, a present fingerprint of memory of the selected executing process where the selected executed process is within the at least one process ; determining , by the processor a difference between the respective starting fingerprint of the selected executing process and the present fingerprint of the selected executing process ; and reporting, based on determining the difference, an indication of the difference for the selected executing process . determining, by a processor of a device during a system startup phase that starts privileged software processes that initialize the device and that is prior to transitioning to a device operational phase wherein any software present on the device is able to execute, a respective starting fingerprint of memory of each executing process within at least one process other than a kernel process, each executing process in the at least one process being started after the kernel process and during the system startup phase; determining, by the processor during the device operational phase and while a selected executing process is executing, a present fingerprint of memory of the selected executing process where the selected executed process is within the at least one process ; determining , by the processor a difference between the respective starting fingerprint of the selected executing process and the present fingerprint of the selected executing process ; and reporting, based on determining the difference, an indication of the difference for the selected executing process .
A small remote-acting electroshock weapon comprising a non-conductive housing with a cavity for a firing cartridge activated by a low voltage and having launchable current-conducting wires and a pyrotechnic device arranged inside the firing cartridge for releasing the cartridge from the housing of the weapon, a source of electrical energy, and a high voltage stunning pulse generator having an electrical deactivation switch, wherein the weapon further comprises a movable mechanical safety trigger which can be controlled by a finger of the hand holding the weapon and which is able to interact with the electrical deactivation switch of the high voltage stunning pulse generator and with an additional electrical switch for preventing firing of the firing cartridge; a safety lock for preventing movement of the safety trigger in the event of unauthorized movement thereof and for locking the firing cartridge in the housing during firing; and a catch for locking the firing cartridge in the housing, said catch being controllable by the hand with which the user is holding the weapon.
Mechanical assembly for a vehicle, in particular a motor vehicle, comprising: - a rotating element , - a support for the rotating element , and - a cover fixed to the support for the rotating element , the cover comprising at least one edge fixed to the support for the rotating element and a bottom extending substantially in a plane, the bottom being covered at least in part by elastomeric material , further comprising an electronic board for controlling the rotating element , the support for the rotating element forming, with the cover , a housing for receiving the electronic board , the mechanical assembly for a vehicle being characterized in that the support for the rotating element has at least one projecting relief, in contact with the cover , in particular with the bottom of the cover , the projecting relief passing through the electronic board , and in that the rotating element is an external rotor of an electric motor , a stator of the electric motor being interposed between the external rotor and a cylindrical relief of the support for the rotating element . - a rotating element , - a support for the rotating element , and - a cover fixed to the support for the rotating element , the cover comprising at least one edge fixed to the support for the rotating element and a bottom extending substantially in a plane, the bottom being covered at least in part by elastomeric material , further comprising an electronic board for controlling the rotating element , the support for the rotating element forming, with the cover , a housing for receiving the electronic board , the mechanical assembly for a vehicle being characterized in that the support for the rotating element has at least one projecting relief, in contact with the cover , in particular with the bottom of the cover , the projecting relief passing through the electronic board , and in that the rotating element is an external rotor of an electric motor , a stator of the electric motor being interposed between the external rotor and a cylindrical relief of the support for the rotating element .
A process for treating, with a plasma, a composition comprising at least a first compound and a second compound, characterized in that said process comprises at least: - generating, within an enclosure, a non-equilibrium plasma flow from a gas present in said enclosure by maintaining the pressure within the enclosure below 10 000 Pa, and - treating the composition contained in said enclosure with said non-equilibrium plasma flow so as to extract at least a portion of said first compound, wherein the extracted first compound is in a gaseous state and is captured in a liquid or solid state in a carbon felt traversed by the non-equilibrium plasma flow comprising said extracted first compound, wherein the temperature of the carbon felt is lower than the condensation point or lower than the solidification point of the first compound. - generating, within an enclosure, a non-equilibrium plasma flow from a gas present in said enclosure by maintaining the pressure within the enclosure below 10 000 Pa, and - treating the composition contained in said enclosure with said non-equilibrium plasma flow so as to extract at least a portion of said first compound, wherein the extracted first compound is in a gaseous state and is captured in a liquid or solid state in a carbon felt traversed by the non-equilibrium plasma flow comprising said extracted first compound, wherein the temperature of the carbon felt is lower than the condensation point or lower than the solidification point of the first compound.
A medical apparatus , comprising: a processor ; and a communication unit , one or more acoustical sensors; a sensor comprising a keyboard, a touch-screen device, an adjustment wheel, or a button; wherein the medical apparatus is configured to perform: using the one or more acoustical sensors to sense a speech instruction provided by a user; determining the speech instruction provided by the user based on operational data stored within the medical apparatus; characterised in that the medical apparatus is further configured to perform: presenting the determined instruction to the user; receiving correction of the wrongly determined instruction by operation of the sensor by the user; adjusting the determined instruction using the received correction; presenting the correctly determined instruction to the user; performing an action constituted by the correctly determined instruction; transmitting a representation of the speech instruction, the determined instruction, and the correction or the correctly determined instruction to a server ; receiving modification information from the server; and using the modification information to modify the operational data stored within the medical apparatus. a processor ; and a communication unit , one or more acoustical sensors; a sensor comprising a keyboard, a touch-screen device, an adjustment wheel, or a button; using the one or more acoustical sensors to sense a speech instruction provided by a user; determining the speech instruction provided by the user based on operational data stored within the medical apparatus; characterised in that the medical apparatus is further configured to perform: presenting the determined instruction to the user; receiving correction of the wrongly determined instruction by operation of the sensor by the user; adjusting the determined instruction using the received correction; presenting the correctly determined instruction to the user; performing an action constituted by the correctly determined instruction; transmitting a representation of the speech instruction, the determined instruction, and the correction or the correctly determined instruction to a server ; receiving modification information from the server; and using the modification information to modify the operational data stored within the medical apparatus. presenting the determined instruction to the user; receiving correction of the wrongly determined instruction by operation of the sensor by the user; adjusting the determined instruction using the received correction; presenting the correctly determined instruction to the user; performing an action constituted by the correctly determined instruction; transmitting a representation of the speech instruction, the determined instruction, and the correction or the correctly determined instruction to a server ; receiving modification information from the server; and using the modification information to modify the operational data stored within the medical apparatus.
A process for preparing ( E )-(5,6-dihydro-1,4,2-dioxazin-3-yl)(2-hydroxyphenyl)methanone O-methyl oxime, comprising : (i) reacting benzofuran-3(2 H )-one O -methyl oxime with at least one nitrite selected from n-butyl nitrite and tert-butyl nitrite, in the presence of a metal alkoxide and an aprotic bipolar solvent which is N,N-dimethylformamide, dimethylsulfoxide, N-methyl-2-pyrrolidone, or a combination thereof, to form a composition where one isomer predominates and (2 Z ,3 Z )-2,3-benzofuran-dione O 3 -methyl dioxime is the predominant isomer; (ii) reacting the -2,3-benzofuran-dione O 3 -methyl dioxime with 2-haloethanol to form (2 Z ,3 Z )-benzofuran-2,3-dione O 2 -(2-hydroxyethyl) O 3 -methyl dioxime ; and (iii) reacting the (2 Z ,3 Z )-benzofuran-2,3-dione O 2 -(2-hydroxyethyl) O 3 -methyl dioxime with an acid to form ( E )-(5,6-dihydro-1,4,2-dioxazin-3-yl)(2-hydroxyphenyl)methanone O -methyl oxime ; (i) reacting benzofuran-3(2 H )-one O -methyl oxime with at least one nitrite selected from n-butyl nitrite and tert-butyl nitrite, in the presence of a metal alkoxide and an aprotic bipolar solvent which is N,N-dimethylformamide, dimethylsulfoxide, N-methyl-2-pyrrolidone, or a combination thereof, to form a composition where one isomer predominates and (2 Z ,3 Z )-2,3-benzofuran-dione O 3 -methyl dioxime is the predominant isomer; (ii) reacting the -2,3-benzofuran-dione O 3 -methyl dioxime with 2-haloethanol to form (2 Z ,3 Z )-benzofuran-2,3-dione O 2 -(2-hydroxyethyl) O 3 -methyl dioxime ; and (iii) reacting the (2 Z ,3 Z )-benzofuran-2,3-dione O 2 -(2-hydroxyethyl) O 3 -methyl dioxime with an acid to form ( E )-(5,6-dihydro-1,4,2-dioxazin-3-yl)(2-hydroxyphenyl)methanone O -methyl oxime ;
An information processing apparatus comprising: a detection unit configured to detect a corneal reflection image corresponding to light from a light source reflected at a cornea from a captured image in which an eye irradiated with the light from the light source is imaged, characterised in that the detection unit estimates a position of a center of an eyeball on the basis of a plurality of time-series captured images each of which is the captured image according to the above, estimates a position of a center of the cornea on the basis of the estimated position of the center of the eyeball, estimates a position of a candidate for the corneal reflection image on the basis of the estimated position of the center of the cornea, and detects the corneal reflection image from the captured image on the basis of the estimated position of the candidate for the corneal reflection image. a detection unit configured to detect a corneal reflection image corresponding to light from a light source reflected at a cornea from a captured image in which an eye irradiated with the light from the light source is imaged, characterised in that the detection unit estimates a position of a center of an eyeball on the basis of a plurality of time-series captured images each of which is the captured image according to the above, estimates a position of a center of the cornea on the basis of the estimated position of the center of the eyeball, estimates a position of a candidate for the corneal reflection image on the basis of the estimated position of the center of the cornea, and detects the corneal reflection image from the captured image on the basis of the estimated position of the candidate for the corneal reflection image.
A chemical compound carrier for improving the biocompatibility of a therapeutic agent and for increasing the solubility of a hydrophobic or lipophilic agent in water, said carrier comprising a molecular structure represented by the formula: wherein: H is a lipophilic carrier void of steroid acids and fatty acids, and being selected from the group consisting of cholesterol, sterols having a single hydroxyl group including stanols, Vitamin D, cholecalciferols, ergocalciferol, Vitamin A, retinoids, carotenoids, tocopherols, and tocotrienols; Sugar is a carbohydrate selected from the group consisting of monosaccharides, disaccharides, and trisaccharides; PEG is a polyethylene glycol polymer; Backbone is a molecule having three or four available binding positions and being void of a drug moiety, said Backbone comprising at least one of glycerol, diamines, triamines, tetraamines, diaminoalcohols, aminoalcohols, aminodiols, aminotriols, amino acids having three available binding positions, triols, tetraols, triacids, tetraacids, halogen-containing diols, halogen-containing amines, carboxyl-containing diols and polyamines. H is a lipophilic carrier void of steroid acids and fatty acids, and being selected from the group consisting of cholesterol, sterols having a single hydroxyl group including stanols, Vitamin D, cholecalciferols, ergocalciferol, Vitamin A, retinoids, carotenoids, tocopherols, and tocotrienols; Sugar is a carbohydrate selected from the group consisting of monosaccharides, disaccharides, and trisaccharides; PEG is a polyethylene glycol polymer; Backbone is a molecule having three or four available binding positions and being void of a drug moiety, said Backbone comprising at least one of glycerol, diamines, triamines, tetraamines, diaminoalcohols, aminoalcohols, aminodiols, aminotriols, amino acids having three available binding positions, triols, tetraols, triacids, tetraacids, halogen-containing diols, halogen-containing amines, carboxyl-containing diols and polyamines.
A transfer coupling comprising a static component and a rotatable component arranged in co-axial alignment, the static component including a first number of ports and the rotatable component including a second number of ports , the ports being arranged in a common circumferential plane wherein the ports are configured and arranged, in use, to homogenise a flow area for a fluid being transferred through the ports and thereby create a homogenous volume flow, characterized in that each of the static and rotatable components comprises a web consisting of a pair of equal diameter, coaxially aligned annuli connected by a plurality of axially extending, equally spaced struts defining spaces and in a circumferential direction, the struts have a smaller dimension than the spaces .
A method for manufacturing a container for storing liquids, comprising the steps of: (a) preparing a container including an inner layer including a storage space (B) for storing liquids; an outer layer ; and at least one spacer fastened between the inner layer and the outer layer to form a plurality of compartments (A), the spacer including a first surface secured to an adhesive layer of the inner layer , the first surface having a plurality of cavities , and a second surface secured to the outer layer ; (b) pressurizing and heating, wherein heat and pressure are exerted on the adhesive layer simultaneously in a direction from the storage space (B) to the outer layer , the adhesive layer is melted and deformed into the cavities ; wherein the adhesive layer is a fluorine-containing thermoplastic and is heated to a temperature higher than the melting point of the adhesive layer ; (c) cooling wherein the portions of the adhesive layer melted and deformed in the cavities are cooled so as to form a plurality of projections complementarily secured to the cavities ; and (d) finishing so that a container for storing liquids is produced. (a) preparing a container including an inner layer including a storage space (B) for storing liquids; an outer layer ; and at least one spacer fastened between the inner layer and the outer layer to form a plurality of compartments (A), the spacer including a first surface secured to an adhesive layer of the inner layer , the first surface having a plurality of cavities , and a second surface secured to the outer layer ; (b) pressurizing and heating, wherein heat and pressure are exerted on the adhesive layer simultaneously in a direction from the storage space (B) to the outer layer , the adhesive layer is melted and deformed into the cavities ; wherein the adhesive layer is a fluorine-containing thermoplastic and is heated to a temperature higher than the melting point of the adhesive layer ; (c) cooling wherein the portions of the adhesive layer melted and deformed in the cavities are cooled so as to form a plurality of projections complementarily secured to the cavities ; and (d) finishing so that a container for storing liquids is produced.
A nucleic acid biomarker set for predicting or diagnosing a disease related to microbiota in a subject or determining whether a subject is at the risk of developing the disease, comprising the following biomarkers: MLG 317 consisting of nucleic acids with the sequence of SEQ ID NO: 933-1052; MLG 3770 consisting of nucleic acids with the sequence of SEQ ID NO: 1053-1281; and MLG 3840 consisting of nucleic acids with the sequence of SEQ ID NO: 238-639; optionally, the biomarker set further comprises one or more of the following biomarkers: MLG 665 consisting of nucleic acids with the sequence of SEQ ID NO: 640-932; MLG 721 consisting of nucleic acids with the sequence of SEQ ID NO: 120-237; MLG 1738 consisting of nucleic acids with the sequence of SEQ ID NO: 1471-2436; MLG 1340 consisting of nucleic acids with the sequence of SEQ ID NO: 2893-3067; MLG 5954 consisting of nucleic acids with the sequence of SEQ ID NO: 1-119; MLG 711 consisting of nucleic acids with the sequence of SEQ ID NO: 1282-1470; and MLG 4668 consisting of nucleic acids with the sequence of SEQ ID NO: 2437-2892; preferably, the biomarker set comprises the nucleic acid biomarkers as defined in - wherein the disease is advanced adenoma in colorectum. MLG 317 consisting of nucleic acids with the sequence of SEQ ID NO: 933-1052; MLG 3770 consisting of nucleic acids with the sequence of SEQ ID NO: 1053-1281; and MLG 3840 consisting of nucleic acids with the sequence of SEQ ID NO: 238-639; optionally, the biomarker set further comprises one or more of the following biomarkers: MLG 665 consisting of nucleic acids with the sequence of SEQ ID NO: 640-932; MLG 721 consisting of nucleic acids with the sequence of SEQ ID NO: 120-237; MLG 1738 consisting of nucleic acids with the sequence of SEQ ID NO: 1471-2436; MLG 1340 consisting of nucleic acids with the sequence of SEQ ID NO: 2893-3067; MLG 5954 consisting of nucleic acids with the sequence of SEQ ID NO: 1-119; MLG 711 consisting of nucleic acids with the sequence of SEQ ID NO: 1282-1470; and MLG 4668 consisting of nucleic acids with the sequence of SEQ ID NO: 2437-2892; preferably, the biomarker set comprises the nucleic acid biomarkers as defined in - wherein the disease is advanced adenoma in colorectum.